✦ LIBER ✦

Biomarkers (VEGF, BFGF) for assessing the biological activity of PTK787/zk222584 (PTK/ZK), a vascular endothelial growth factor (VEGF) receptor inhibitor, in tumours known to overexpress VEGF

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose escalation, pharmacokinetic

✍ Drevs, J.; Mross, K.; Reusch, P.; Peng, B.; Ball, H.; Henry, A.; Laurent, D.; Du 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Defining the biologically active dose fo

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 141 KB

PTK787/ZK 222584, a small molecule tyros

✍ Francis J. Giles; Alan F. List; Michael Carroll; Jorge E. Cortes; Joyce Valickas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Biomarkers for assessment of pharmacolog

✍ Lucy Lee; Sunil Sharma; Bruno Morgan; Peter Allegrini; Christian Schnell; Josef 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 427 KB

A phase I study of the oral vascular end

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Simultaneous application of the vascular

✍ Natalie Inteeworn; Stefanie Ohlerth; Gisele Höpfl; Franco Guscetti; Carla Rohrer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 466 KB